From Yahoo here an exiting input from an insider in MD:
(if brought here already no harm done)
Especially the last part of article that talks about the 'problem of being compared to 'Over the counter Fish Oils' - has to be taken serious.
Marketing experts needs to 'find the right approach to handle that problem 'head on'.
------------------------------------
The article from Yahoo - with thanks to 'Heart Doc'
Heart Doc MD15 hours ago
Continued from previous post:
Those who address the "shorts" or are waiting for a short squeeze...forget about it. You are wasting your time. You saw only about 5 million short shares cover after the FDA approval. Those are the retail shorts. No retail short who knew anything about AMRN or Vascepa would stay short at that point. The risk has been removed from this company. Lawsuit is a formality. From what I heard, they had multiple opportunities to settle but, need to have a legal decision in the record to prevent endless additional lawsuits going forward. A settlement would have been good for short term share price but detrimental long term. It's a formality. Wall Street and AMRN expect a favorable ruling. The 45 million short shares left are hedges, spreads, etc. AMRN is under pure control. The share price can not go above $25 for this reason. It will stay between 18-24.90 until one morning you wake up and it is bought out for a huge premium. So just forget about commenting on the shorts. The ones you are addressing hold a meaningless number of shares. As one of the reps said to me..."if the price can be controlled on days when 60 million and 30 million shares are traded, then it can be controlled or manipulated any day."
It is difficulty, but sit back and check on the price once a week (Mondays). If you have funds available, buy when it is oversold and hold until buyout. Any other strategy will drive you insane or penniless.
Just saw most recent SV post. Please stay away from any of the medical aspect of Vascepa. Your analysis are silly, in lay terms, and not accurate. "Blood stream, clean out, detoxify, and so many more ideas are so far off from what is going on. If you really want to get a better idea, go find on you tube Dr. Deebak Bhatt's Grand Rounds in Texas from October. I don't want to get into it but atherosclerosis is an inflammatory process. It happens in the vessel wall leading to plaque deposition. There are many intricacies of plaque including even plaque rupture or MI. It is not one pathway or mechanism. "The blood stream" has little to nothing to do with things. The plaque in Alzheimer's is a protein plaque, not a lipid plaque. The mechanism of preventing this plaque deposition is completely different. The potential effects on fattly liver (NASH) are a different mechanism from both of these. There are dozens of potential pathways that Vascepa may be or is likely working. Your medical comments just harm your thoughtful posts. Stay away from them until you have an MD after your name. Stick to your due diligence. You dig up many interesting things. Keep your imagination at bay...please.
Ok, I think that is enough to offer some perspective. Bash if you want. I really don't care. Vascepa is a breakthrough medication and is changing the paradigm.
Oh one last thing I didn't bring up in the earlier post about how they can't ramp up as fast as some on this board predict. Most doctors don't know about it or if they do, they don't believe in it because they are not familiar with the data. Out of the 100+ cardiologist at my institution, a handful prescribe it regularly. I cathed a young patient last week. Had 3 vessel CAD. Had DMII. Saw his endocrinologist the week before. Had TG 222. HTN. Had PAD. ....and was not on Vascepa. I called his clinical cardiologist and stated I was starting him on Vascepa. His response to me was a laugh...and then said "fish-oil, you're drinking the cool-aid." This is the easiest med I have ever prescribed to pt's. Even their family members in the room want it. This is the hardest med to convince other doctors to start prescribing. Overcoming the decade of mixed data on fish oil is a major barrier. It is difficult for me to convince my colleagues....it is even harder for new reps to convince them. This is real. I could really send one more post regarding all the insurance issues that are going on right now but, need to get to bed. Maybe next weekend.
